A detailed history of Avidity Partners Management LP transactions in Incyte Corp stock. As of the latest transaction made, Avidity Partners Management LP holds 129,600 shares of INCY stock, worth $9.35 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
129,600
Previous 308,110 57.94%
Holding current value
$9.35 Million
Previous $20.4 Million 56.05%
% of portfolio
1.01%
Previous 1.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$65.08 - $83.38 $11.6 Million - $14.9 Million
-178,510 Reduced 57.94%
129,600 $8.95 Million
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $12.7 Million - $15.2 Million
-220,890 Reduced 41.76%
308,110 $20.4 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $27.1 Million - $33.7 Million
529,000 New
529,000 $32.1 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.